Salesforce on its longest losing streak ever — bet the pain continues
Salesforce's stock has fallen for 14 straight days, a company record. Investors are heavily selling the stock because they don't believe the company's artificial intelligence features will generate the revenue they once hoped for.
Idea
A 14-day consecutive losing streak is incredibly rare and signals deep pessimism from large investors. Without a credible AI growth story to turn the narrative around, buyers are staying away, creating a dire lack of demand. When a stock is in a historic slump without a clear catalyst for a turnaround, trend-following strategies can effectively capture the ongoing downward momentum.
Advanced Analysis — institutional-depth research report
Verdict: wait — the losing streak ended, and the short never had a working trigger
**Verdict: wait — the tape has moved against this short, and the rules never fired anyway.** The strongest point for the idea is behavioral: per the MarketWatch piece of June 22, 2026, Salesforce just posted a record 14-session losing streak on AI-revenue doubt, the kind of sustained distribution a breakdown short feeds on. The strongest point against is that the trade has inverted since then — CRM closed at $256.93, just 1.2% below its $260 resistance, with RSI (14) at 84.7 and ROC (10) at +24.7%. The compiled entry rules produced zero trades across 60 months and 1,237 daily bars, and the sensitivity evaluation returned no robust parameter setup. The fundamentals are genuinely mixed: the April 2026 quarter showed revenue down 73% sequentially to $11.1B and free cash flow down 54% to $6.6B, with debt-to-equity jumping from 0.18 to 1.15 — but much of that is software seasonality. Full-year revenue grew 36.9% to $41.5B, free cash flow sits in the 99th peer percentile, margins improved, and shares outstanding fell 11.8% on buybacks, with the dividend raised to $1.71 trailing per share. The June 30, 2026 institutional snapshot (9 holders, 2.0M shares) has passed its update deadline, so the thesis's claim of continued institutional selling is unverified. Conviction is low across the board; wait for price to prove the demand-void narrative before doing anything.
Trade now: the entry is not live — here is exactly what has to change
There is nothing to trade today, and that is the honest starting point. The idea argues that CRM's record losing streak makes a breakdown short attractive, but the compiled entry conditions have not been met on live bars — this is a watch-list setup, not an active signal. CRM last closed at $256.93, sitting just 1.2% below its nearest resistance at $260 and well above its nearest support at $250. The momentum picture actually cuts against the short thesis right now: RSI (14) is at 84.7, ROC (10) is at +24.7%, and price sits 71% above its 52-week range low — the stock has been rallying, not breaking down. Checking each entry condition live: ADX (14) at 70.1 is above its 20 threshold (met), the Donchian (20) condition is met, but the momentum and accumulation conditions are far from triggering — the daily low condition cannot be satisfied at any realistic price, and OBV data is not currently available. In plain terms, several conditions would need to invert hard before an entry could fire, and one condition as compiled is effectively untriggerable. On risk control if an entry ever went live: the strategy carries a 2.5% stop and a 5% profit target, an effective reward-to-risk of about 2:1, with position risk capped at roughly 2.5% of equity and a maximum position size of 25%. Those are the numbers to hold the trade to — no improvising. One scope note that affects the action plan: this strategy is not backtestable as compiled, because the entry rules never triggered across 60 months of daily data. The optimization review found the compiled entry inconsistent with the short thesis, and no robust parameter setup was established — so treat every level below as a watch item, not a validated signal.
Fourteen down days in a row: the market is telling you something
The core of this idea is behavioral, and the cited MarketWatch piece from June 22, 2026 gives it teeth: Salesforce's stock extended a record 14-session losing streak, the longest in company history, on investor doubt that its AI features will deliver the revenue once hoped. Fourteen consecutive down days is not noise — it is sustained institutional distribution without a bounce, and the thesis argues that buyers are staying away precisely because no credible AI growth catalyst has emerged. For a short-biased momentum setup, that is…
Scores
- Conviction score breakdown: 31
- Thesis support: 40
- Trade readiness: 15
- Risk quality: 40
- Trigger proximity: 15
- Fundamentals trend: 45
Watch items
- CRM — Close vs nearest support
- CRM — Close vs nearest resistance
- CRM — ROC (10)
- CRM — RSI (14)
- CRM — OBV crossing below zero
- CRM — Dividend ex-date
- CRM — XBRL quarterly facts
- CRM — Institutional 13F update
- CRM — Price below 0
- CRM — ADX (14) above 20
- CRM — ROC (10) below 0
- CRM — Donchian (20) above 1
- CRM — Price above 0